首页> 外国专利> The anticancer agent emulsion and its manufacturing method null which for target chemotherapy possess stability and the controlled release operation which are improved

The anticancer agent emulsion and its manufacturing method null which for target chemotherapy possess stability and the controlled release operation which are improved

机译:具有针对目标化疗的稳定性和控释操作得到改善的抗癌剂乳液及其制备方法无效

摘要

PURPOSE: To obtain the subject emulsion capable of effectively distributing an anticancer agent to a tumor part and simultaneously improving the target accuracy of the anticancer agent, comprising a water phase containing the anticancer agent and an oil phase containing an oil and a HCO-60 hydrophilic surfactant. CONSTITUTION: An oil phase containing an oil (preferably lipiodol) in an amount of 10-30wt.% based on a prepared emulsion and a hydrophilic surfactant HCO-60 (polyoxyethylene hydrogenated castor oil having 14 HLB) in an amount of 0.1-2.0wt.%, preferably 0.5-1.5wt.% based on the prepared emulsion is formulated with an aqueous solution of an anticancer agent, then stirred in a homogenizer at 50-100 deg.C to give a mixture, which is emulsified to give the objective emulsion. Adriamycin hydrochloride, bleomycin hydrochloride, mitomycin hydrochloride, cytosine C, cyclophosphamide, cytosine arabinoside, methotrexate, actinomycin, cisplastin, daunomycin hydrochloride, and epirubicin hydrochloride are cited as the anticancer agent.
机译:用途:获得能够有效地将抗癌剂分配到肿瘤部位并同时提高抗癌剂目标精确度的主题乳剂,其包括含有抗癌剂的水相和含有油和HCO-60亲水剂的油相表面活性剂。组成:一种油相,其中包含以制备的乳液为基准的10-30wt。%的油(最好是碘油)和0.1-2.0wt%的亲水性表面活性剂HCO-60(聚氧乙烯氢化蓖麻油,含量为14 HLB)以所制备的乳液为基准,将0.1%,优选0.5-1.5wt%的抗癌剂水溶液配制,然后在均质器中于50-100℃搅拌以得到混合物,将其乳化以得到目标。乳液。盐酸阿霉素,盐酸博来霉素,盐酸丝裂霉素,胞嘧啶C,环磷酰胺,胞嘧啶阿拉伯糖苷,甲氨蝶呤,放线菌,顺铂,盐酸道诺霉素和盐酸表柔比星被称为抗癌剂。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号